Skip to content

Author

Lamia K. Alshamlani

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Development of immune-related adverse events is associated with improved survival outcomes in cancer patients receiving immune checkpoint inhibitors

Immune checkpoint inhibitors (ICIs) have become the standard-of-care in various cancer types. However, treatment with ICIs occasionally cause immune-related adverse events (irAEs). This study assessed the incidence and clinical features of irAEs and examined their association with treatment outcomes in patients with so...

Faizah Alotaibi, Seham Khashwayn, Lamia K. Alshamlani et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.